Lyrica (Pregabalin) Korean Post Marketing Surveillance Study

NCT01220180 · clinicaltrials.gov ↗

COMPLETED

Status

4175

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Neuropathic Pain
Fibromyalgia
Post-market Surveillance

Interventions

DRUG: pregabalin (Lyrica)
DRUG: pregabalin (Lyrica)
DRUG: pregabalin (Lyrica)

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.